Canaccord Genuity Group Reaffirms “Hold” Rating for Olink Holding AB (publ) (NASDAQ:OLK)

Canaccord Genuity Group reaffirmed their hold rating on shares of Olink Holding AB (publ) (NASDAQ:OLK) in a research note released on Tuesday morning, Benzinga reports. They currently have a $26.00 price objective on the stock.

Olink Holding AB (publ) Price Performance

Shares of NASDAQ:OLK opened at $23.51 on Tuesday. The business’s 50 day simple moving average is $23.93 and its 200-day simple moving average is $22.95. The firm has a market capitalization of $2.92 billion, a price-to-earnings ratio of -94.04 and a beta of 0.49. Olink Holding AB has a 12 month low of $14.10 and a 12 month high of $26.01.

Institutional Investors Weigh In On Olink Holding AB (publ)

Institutional investors have recently modified their holdings of the company. TD Asset Management Inc boosted its stake in shares of Olink Holding AB (publ) by 73.7% during the 3rd quarter. TD Asset Management Inc now owns 403,924 shares of the company’s stock worth $5,958,000 after acquiring an additional 171,395 shares in the last quarter. Trexquant Investment LP boosted its stake in shares of Olink Holding AB (publ) by 23.0% during the 3rd quarter. Trexquant Investment LP now owns 33,156 shares of the company’s stock worth $489,000 after acquiring an additional 6,193 shares in the last quarter. US Bancorp DE boosted its stake in shares of Olink Holding AB (publ) by 874.4% during the 2nd quarter. US Bancorp DE now owns 9,666 shares of the company’s stock worth $181,000 after acquiring an additional 8,674 shares in the last quarter. Rock Springs Capital Management LP raised its position in shares of Olink Holding AB (publ) by 1.4% during the 3rd quarter. Rock Springs Capital Management LP now owns 1,676,500 shares of the company’s stock worth $24,728,000 after purchasing an additional 22,500 shares during the last quarter. Finally, New York State Common Retirement Fund raised its position in shares of Olink Holding AB (publ) by 3.7% during the 3rd quarter. New York State Common Retirement Fund now owns 67,166 shares of the company’s stock worth $991,000 after purchasing an additional 2,368 shares during the last quarter. Hedge funds and other institutional investors own 30.19% of the company’s stock.

Olink Holding AB (publ) Company Profile

Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.